Technical Analysis for NWBO - Northwest Bioth Cmn

Grade Last Price % Change Price Change
grade D 0.1991 0.56% 0.0011
NWBO closed up 0.56 percent on Tuesday, August 20, 2019, on 1.22 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NWBO trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish 0.56%
Shooting Star Candlestick Bearish 0.56%
Lizard Bearish Bearish Day Trade Setup 0.56%
180 Bearish Setup Bearish Swing Setup 0.56%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.56%
New Uptrend Bullish 0.56%
Volume Surge Other 0.56%
Outside Day Range Expansion 0.56%

Older signals for NWBO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.
Medicine Health Biotechnology RTT Cancer Clinical Medicine Antibodies Immunotherapy Cancer Immunotherapy Platform Technology Tumors Virotherapy Solid Tumor Cancers Northwest Biotherapeutics Tumor Antigen Vaccine
Is NWBO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.35
52 Week Low 0.175
Average Volume 889,424
200-Day Moving Average 0.2639
50-Day Moving Average 0.2401
20-Day Moving Average 0.2158
10-Day Moving Average 0.2051
Average True Range 0.0156
ADX 24.16
+DI 14.2332
-DI 14.0496
Chandelier Exit (Long, 3 ATRs ) 0.1932
Chandelier Exit (Short, 3 ATRs ) 0.2409
Upper Bollinger Band 0.2404
Lower Bollinger Band 0.1912
Percent B (%b) 0.16
BandWidth 22.798888
MACD Line -0.0111
MACD Signal Line -0.0117
MACD Histogram 0.0005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2126
Resistance 3 (R3) 0.2131 0.2090 0.2104
Resistance 2 (R2) 0.2090 0.2056 0.2088 0.2096
Resistance 1 (R1) 0.2041 0.2035 0.2021 0.2036 0.2088
Pivot Point 0.2000 0.2000 0.1990 0.1998 0.2000
Support 1 (S1) 0.1951 0.1966 0.1931 0.1946 0.1894
Support 2 (S2) 0.1910 0.1945 0.1908 0.1886
Support 3 (S3) 0.1861 0.1910 0.1879
Support 4 (S4) 0.1856